Edwards Lifesciences (NYSE:EW) had its price target raised by analysts at Royal Bank Of Canada from $95.00 to $100.00. They now have an "outperform" rating on the stock.
Edwards Lifesciences (NYSE:EW) was given a new $100.00 price target on by analysts at Stifel Nicolaus.
Edwards Lifesciences (NYSE:EW) was given a new $92.00 price target on by analysts at Truist Financial Corporation.
Edwards Lifesciences (NYSE:EW) was given a new $89.00 price target on by analysts at Canaccord Genuity Group Inc..
Edwards Lifesciences (NYSE:EW) had its price target raised by analysts at Robert W. Baird from $83.00 to $88.00. They now have a "neutral" rating on the stock.